The 2006 Project Award cycle is completed and we are excited about the selected projects underway.
The Request for Application (RFA) for our next award cycle will be posted in February 2007. Please visit our website at that time for further details.
In the meantime, the 2006 RFA and Application Procedures remain posted for reference (see below). For further inquiry, please contact Joanne Salcido by telephone (925-838-5300) or e-mail ([email protected]).
2006 Request for Application
Accelerate Brain Cancer Cure (ABC2) is soliciting proposals for the 2006 Project Awards, a program established to fund projects with near-term potential to significantly improve treatment outcomes and disease management for brain cancer patients. Support from the Tug McGraw Foundation enables us to extend funding to include a study targeting quality of life in patients with brain cancer.
We are seeking to fund research that translates promising laboratory successes into clinically meaningful improvements. Targeting the acceleration of progress in what has been an underserved field of research; our approach is designed to provide innovative researchers with the support they require to make critical translational breakthroughs. Our purpose is to fund proposals that will have an immediate impact. We will work actively and partner with investigators to overcome obstacles in achieving the goal of the research.
The funding preference in 2006 is for translational research in the following areas:
We emphasize that in this RFA we will only consider applications that address the above targeted areas. Central to our approach is a fast-track awards process geared to provoke new ideas and move the science forward quickly and efficiently. Award applications are limited to five pages and will be peer reviewed by a select group of experts in the field. Applications must be received electronically by 5:00 pm EST on March 31, 2007.
- Non-invasive diagnostic and prognostic markers of disease status and response to therapy in glioma (includes serological biomarkers, anatomic/physiologic imaging)
- Mechanism of action of bevacizumab-based therapies in glioma
- Studies targeting quality of life/support of care in patients with brain cancer
- Development of molecular targeted therapeutics for brain cancer (with emphasis placed on studies that will lead to clinical trials within 18 months)
Each application will be reviewed by a panel of experts in the field and recommendations will be presented to the Board of Directors of ABC2 and the Tug McGraw Foundation. All applicants will be contacted by e-mail with the final decision on or before April 28, 2006.
Selected applications will be awarded for a one year period up to a maximum of $250,000. To date, ABC2 has awarded 46 awards from 18 institutions at an average size of $100,000. Indirect costs are not funded.
Applications for the 2006 Project Awards must be submitted online and must include 1) a completed Application form, and 2) a Research Proposal as a PDF file (Acrobat format).
To view the Application form, click here. Please read all instructions below before submitting your online application.
In addition, applicants must provide a single hard copy of the completed Application Form and the Research Proposal.
INSTRUCTIONS FOR REQUIRED ONLINE SUBMISSION OF APPLICATION
Online submission of applications is a 3-step process:
1) fill out the Application form online (form accessed through link below)
2) attach the Research Proposal as a PDF file (see instructions for Proposal and for preparation of PDF file below)
3) click on the TRANSMIT button to submit completed Application form and attached PDF file of your Research Proposal
Receipt of completed applications will be confirmed by e-mail.
To initiate online submission of application, click here.
REQUIREMENTS FOR RESEARCH PROPOSAL
Required headings, inclusive in a 5-page narrative:
Note: Figures and tables that directly accompany the above headings in the narrative are not required to fit within the 5-page limit.
- Specific Aims
- Preliminary Studies
- Other funding sources. Please address the following questions:
Could your research lead to funding from other sources? If so, which sources?
- Project scope. Please address the following questions:
Is this research project part of a larger project? Is it an independent research project?
Required headings, NOT inclusive in the 5-page limit:
All pages of the Research Proposal must be numbered in footer. Also, the name of Principal Investigator (Last , First ) must be indicated in the header on all pages of the Research Proposal.
- CV/Biosketch for Principal Investigator and each co-investigator
- Summary budget
- Confirmation of agent procurement (required only if proposal includes testing of agents)
- Confirmation of institution approval of protocol (required only if proposal includes preclinical or clinical testing)
REQUIREMENTS FOR ACROBAT PDF FILE OF RESEARCH PROPOSAL
INSTRUCTIONS FOR REQUIRED HARD COPY
- Research Proposal must be sent as a PDF file (Acrobat format). The PDF file must contain the 5-page narrative first and the accompanying figures and tables (if any) must immediately follow. Thereafter, all other pages of Research Proposal may be in any order.
- The PDF attachment must be no larger than five (5) megabytes total.
- The PDF file must be named exactly as shown with name of Principal Investigator and year of award cycle:
A single hard copy of the completed Application Form (you may print out the Application form that you complete on our website) and of the Research Proposal must be sent along with the online submission of application. The hard copy must be three hole-punched, not stapled, and received at the following address no later than March 31, 2007, 5 pm EST:
Please mail/ship your hard copy application to our new address:
For additional information, please contact us by telephone (202) 419-3140 or e-mail at [email protected] Do not e-mail or fax your application to Award Director — electronic submission must be done online.
Attn: Award Director
1717 Rhode Island Ave., NW, 7th Floor
Washington, DC 20036